March 31, 2017 / 11:12 AM / in 4 months

BRIEF-Incyte and Merck provide additional details on previously announced collaboration

1 Min Read

March 31 (Reuters) - Incyte Corp-

* Incyte and Merck provide additional details on previously announced collaboration investigating epacadostat and Keytruda® (pembrolizumab)

* Says expanded collaboration now includes seven pivotal studies

* Says clinical program on epacadostat and keytruda now include seven registrational trials across five tumor types Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below